HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.30 Cr | ₹-14 Cr | ₹15 Cr | ₹3.80 Cr | ₹-24 Cr |
What is the latest Net Cash Inflow / Outflow ratio of HIKAL ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.30 Cr |
| Mar2024 | ₹-14 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹3.80 Cr |
| Mar2021 | ₹-24 Cr |
How is Net Cash Inflow / Outflow of HIKAL Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.30 Cr | Positive | |
| Mar2024 | ₹-14 Cr | Negative | |
| Mar2023 | ₹15 Cr | 301.92 | |
| Mar2022 | ₹3.80 Cr | Positive | |
| Mar2021 | ₹-24 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,656.5 Cr | -4.3% | -15.9% | -44.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -4.3% |
-15.9% |
-44.1% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses